Related Experiment Video
Updated: May 15, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Meta-analyses of four eosinophil related gene variants in coronary heart disease
Jiangfang Lian1, Yi Huang, R Stephanie Huang
1Ningbo Medical Center, Lihuili Hospital, Ningbo University, Ningbo, 315041, Zhejiang, China.
Insights
Genetic variants in eosinophil-related genes were studied for their link to coronary heart disease (CHD). The SH2B3 gene variant rs3184504 showed a significant association with CHD risk in European and South Asian populations.
Area of Science:
- Genetics
- Cardiovascular Disease Epidemiology
- Immunology
Background:
- Eosinophils play a role in inflammation and immune responses.
- Genetic variations can influence susceptibility to complex diseases like coronary heart disease (CHD).
- Previous research suggests potential links between eosinophil-related genes and cardiovascular health.
Purpose of the Study:
- To investigate the association between four specific eosinophil-related gene variants (rs12619285, rs1420101, rs3184504, and rs4143832) and the risk of developing coronary heart disease (CHD).
- To evaluate the contribution of these genetic variants to CHD risk across different ethnic populations.
Main Methods:
- Conducted systematic literature searches across multiple databases (MEDLINE, EMBASE, Web of Science, CNKI, Wanfang).
- Performed meta-analyses of existing studies and a new case-control study (162 CHD cases, 119 controls).
- Focused meta-analysis on rs3184504 in the SH2B3 gene using 19 study stages and 94,555 participants.
Main Results:
- A significant association was found between the rs3184504 variant in the SH2B3 gene and increased CHD risk in European and South Asian populations (OR = 1.13, 95% CI = 1.10-1.16, p < 0.0001).
- No significant association was observed for rs12619285, rs1420101, and rs4143832 with CHD risk when combining case-control data with previous studies.
- The four genetic variants did not show a significant contribution to CHD risk in the Han Chinese population.
Conclusions:
- The rs3184504 variant of the SH2B3 gene is significantly associated with coronary heart disease risk in European and South Asian populations.
- No significant association was found for the studied eosinophil-related gene variants with CHD risk in the Han Chinese population.
- These findings highlight population-specific genetic influences on coronary heart disease susceptibility.
Abstract:
The goal of our study is to assess the contribution of four eosinophil related gene variants (rs12619285, rs1420101, rs3184504 and rs4143832) to the risk of coronary heart disease (CHD). We conducted four meta-analyses of studies examining the association between four eosinophil related gene variants and the risk of CHD. A systematic search was conducted using MEDLINE, EMBASE, Web of Science and China National Knowledge Infrastructure (CNKI), Wanfang Chinese Periodical. A case-control study was conducted between 162 CHD cases and 119 non-CHD controls to explore their contribution to CHD. For rs3184504 of SH2B3 gene, the meta-analysis was performed among 19 study stages among 94,555 participants. Significant association between rs3184504 and CHD risk was observed in European and South Asian populations (OR = 1.13, 95% CI = 1.10-1.16, p < 0.0001, fixed-effect method). For the other SNPs (rs12619285, rs1420101, and rs4143832), we combined our case-control data with the previous studies and found no association of them with the risk of CHD. No significant contribution of the four genetic variants to CHD was observed in Han Chinese (p > 0.05). In conclusion, our results supported a significant association between rs3184504 of SH2B3 gene and the risk of CHD in Europeans and South Asians, although we were unable to observe association between the four variants and the risk of CHD in Han Chinese.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Single Nucleotide Polymorphisms-SNPs
